that makes no sense as Acadia's share price is galloping and that gallop presumably is not due to its other source of revenue, Nuplazid…see Ken's post below.
my best guess is that some big holder, Milford?, is offloading.
my hoped-for guess is that some entity is deliberately softening up the share price for a deal coming up.
my dreaded guess is that the Angelman’s results are shit and the market is frightened NEU is going to go ahead With expensive and long-drawn out 2591 trial into Phelan McDermid.
my fourth guess is that the market is sick of Neuren's price going nowhere forever and has decided to rotate into more exciting biotechs such as the red-hot radiopharmaceuticals sector!
Acadia, page-694
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |